Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Synthetic biology: Reframing cell therapy for cancer.

Literature DB >> 29443984

Synthetic biology: Reframing cell therapy for cancer.

Taylor B Dolberg¹, Patrick S Donahue^1,2, Joshua N Leonard¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2018 PMID： 29443984 DOI： 10.1038/nchembio.2573

Source DB: PubMed Journal: Nat Chem Biol ISSN： 1552-4450 Impact factor: 15.040

× No keyword cloud information.

6 in total

1. Epic $12 billion deal and FDA's approval raise CAR-T to new heights.

Authors: Elie Dolgin
Journal: Nat Biotechnol Date: 2017-10-11 Impact factor: 54.908

2. FDA Approval of Tisagenlecleucel: Promise and Complexities of a $475 000 Cancer Drug.

Authors: Peter B Bach; Sergio A Giralt; Leonard B Saltz
Journal: JAMA Date: 2017-11-21 Impact factor: 56.272

3. FDA Approves Second CAR T-cell Therapy.

Authors:
Journal: Cancer Discov Date: 2017-11-07 Impact factor: 39.397

Review 4. The Principles of Engineering Immune Cells to Treat Cancer.

Authors: Wendell A Lim; Carl H June
Journal: Cell Date: 2017-02-09 Impact factor: 41.582

5. Nonimmune cells equipped with T-cell-receptor-like signaling for cancer cell ablation.

Authors: Ryosuke Kojima; Leo Scheller; Martin Fussenegger
Journal: Nat Chem Biol Date: 2017-11-13 Impact factor: 15.040

Review 6. Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts.

Authors: Jessica Hartmann; Martina Schüßler-Lenz; Attilio Bondanza; Christian J Buchholz
Journal: EMBO Mol Med Date: 2017-09 Impact factor: 12.137